S1 E6: Pivots, Trials, Errors, and Validation in Product Development with Madhavi Gavini

The Builder Circle · 13 Jun 2023 · 1h 05m

What this episode covers

Madhavi Gavini, CEO of Droplet, discusses the company's journey from a medical device concept to a consumer skincare platform, detailing three major pivots: shifting from rare skin diseases to daily skincare, moving from a B2B dermatologist channel to direct-to-consumer sales during the pandemic, and scrapping an over-engineered chip-reader system to reduce costs. She explains how Droplet manages insourcing core engineering and capsule automation while outsourcing precision manufacturing to partners like East West, and emphasizes the importance of rigorous lifecycle testing to prevent firmware failures. Gavini highlights the sunk cost fallacy, noting how scrapping half a million pre-ordered chips allowed the company to pivot the app’s functionality from simple tracking to multi-mode treatment, ultimately creating a more valuable product for users.

Other shows on the same ground, closest first.

  • Being an Engineer · 43m

    Dakota Welker | User Needs, Design Inputs, Verification & Validation

    Dakota Welker, founder of Think MedTek, explains his four-phase product development methodology for medical device startups, emphasizing user needs, design inputs, verification, and validation. He details how he rescues stalled projects by clarifying scope and documentation, and describes a specific case where bringing manufacturing in-house and negotiating with multiple vendors reduced costs by 50%. Welker also discusses his transition from automotive and pneumatics to medical devices, his focus on CFD tools like Simscale, and the importance of balancing engineering rigor with client communication.

  • Let's Combinate · 35m

    144 - Auto-Injectors, Pen Injectors, Challenges in Product Development, Sponsors and CDMO's with David DeSalvo

    David DeSalvo, Vice-President of Combination Product Development at Kindeva Drug Delivery, details his career trajectory from BD to SHL, Emergent BioSolutions, and finally Kindeva. He distinguishes between pen injectors, auto-injectors, and wearable devices, emphasizing that while connectivity is inevitable, it often adds unnecessary complexity and use errors if not carefully managed. DeSalvo discusses the challenges of transitioning between sponsor and CDMO perspectives, noting that successful partnerships require transparency rather than assuming the other side has the better view. He highlights the importance of balancing innovation with commercial viability, citing early experiences at BD where advanced technologies failed to reach the market due to cost and lack of payer demand.

  • Over the Air · 23m

    Tips for Early-Stage Smart Device Prototyping

    Keith Nothacker, Founder & CEO of BACtrack, discusses the company's journey from a bootstrapped startup to a market leader in breath and transdermal alcohol testing. He emphasizes the critical importance of aggressive early prototyping to uncover design flaws before committing to expensive manufacturing, sharing how BACtrack avoided analysis paralysis by shipping imperfect 'v1' products. Nothacker also details specific early failures, including a rejected Apple Made for iPod integration and a misguided expansion into general health devices, which taught the company to stay focused on core competencies while leveraging smartphone connectivity for added value.

  • Thoroughly Considered · 40m

    3: Onward

    Tom Gerhardt and Dan Provost of Studio Neat discuss the failure of their Obi Kickstarter campaign and how it led to a strategic pivot toward smaller, lower-risk products. They detail the development of the Apple TV Remote Stand, which they manufactured in-house using a desktop CNC router, and the iClip for Apple Watch, produced via Shapeways. The hosts analyze the financial and operational lessons learned from these contrasting approaches to product design, manufacturing, and timing.

  • Let's Combinate · 26m

    176 - The Fastest Way to Ruin Drug/Device Development (And How to Avoid It!) with Eric Sugalski

    Eric Sugalski, founder and CTO of Archimedic, explains that the fastest way to ruin drug-device development is premature concept lock and misaligned outsourcing strategies. He argues that companies must distinguish between needing overflow capacity versus specialized expertise, such as human factors or industrial design, to avoid the 'piecemeal approach' that destroys innovation. Sugalski emphasizes the importance of early, hands-on user research and open-source quality management systems to bridge the gap between engineering and clinical reality, warning that locking down requirements before validating use cases injects costly redo loops into the project.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by The Builder Circle. The episode itself belongs to its publisher.